Skip to content
value.today

Sequelae, Inc.

Total raised
$80 M
2 rounds on record
Latest round
$20 M
Apr 2024
First round on record
Apr 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sequelae, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$20 MNo. 2$10 to $50 million

Sequelae, Inc.: Raise no. 2, Apr 2024

Investors in this round

2 investors had bought by the notice of May 8, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregory Johnson · Executive Officer
  • Ken Ehlert · Executive Officer, Director
  • Mark Briesacher · Executive Officer
  • Mark Pollman · Executive Officer
  • Mike Christy · Executive Officer
  • Sara Taylor · Executive Officer
  • Shiraz Fagan · Executive Officer
  • Albert Zimmerli · Director
  • Amy Schulman · Director
  • David Wichman · Director
  • Rushika Fernandopulle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The estimate is $2,100,000 for one year of salary for all officers.”

Signed by Gregory Johnson, Cfo. Source: SEC Form D, newest notice filed May 8, 2024. Read the notice at the SEC.

equitySEC
Apr 2023$60 MNo. 1$50 to $250 million

Sequelae, Inc.: Raise no. 1, Apr 2023

Investors in this round

7 investors had bought by the notice of Apr 12, 2024: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$60 M of $60 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,800,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregory Johnson · Executive Officer
  • Ken Ehlert · Executive Officer, Director
  • Mark Briesacher · Executive Officer
  • Mark Pollmann · Executive Officer
  • Mike Christy · Executive Officer
  • Shiraz Fagan · Executive Officer
  • Albert Zimmerli · Director
  • Amy Schulman · Director
  • David Wichmann · Director
  • Rushika Fernandopulle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The $60,000,000 is in connection with a SAFE offering and although no actual amount sold, there is no remaining offering amount to be sold.”
  • On the use of proceeds: “The estimate is $1,800,000 for one year of salary for all the officers.”

Signed by Gregory Johnson, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 12, 2024. Read the notice at the SEC.

optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sequelae, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2024

That is all the official record says: Sequelae, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sequelae, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sequelae, Inc.
NameRoleNamed in
Gregory JohnsonExecutive officerMay 2024
Ken EhlertExecutive officerMay 2024
Mark BriesacherExecutive officerMay 2024
Mark PollmanExecutive officerMay 2024
Mike ChristyExecutive officerMay 2024
Sara TaylorExecutive officerMay 2024
Shiraz FaganExecutive officerMay 2024
Mark PollmannExecutive officerApr 2024
Albert ZimmerliDirectorMay 2024
Amy SchulmanDirectorMay 2024
David WichmanDirectorMay 2024
Ken EhlertDirectorMay 2024
Rushika FernandopulleDirectorMay 2024
David WichmannDirectorApr 2024